A study evaluating augmented reality navigation combined with indocyanine green fluorescence in laparoscopic right hemihepatectomy found that this approach significantly reduced intraoperative blood loss (150 ml vs 250 ml) and lowered blood transfusion rates (13.5% vs 39.5%). Additionally, it improved one- and three-year recurrence-free survival rates (81.1% and 73.0% vs 60.5% and 50.0%, respectively). These […]

A novel risk score, PRETREAT, was developed to estimate post-transplant recurrence in patients with perihilar cholangiocarcinoma (pcca) following neoadjuvant therapy and liver transplantation. In a study involving 399 patients, the five-year recurrence rate was 29.7% in the development cohort and 27.6% in the validation cohort. Four predictors—residual tumor, vascular encasement, lymphovascular invasion, and tumor diameter—were […]

A novel CAP score, combining type-IV collagen, albumin, and prothrombin time, effectively predicts 180-day surgery-related mortality in liver resection for hepatocellular carcinoma. With a predictive accuracy (AUC: 0.728), the score identifies risk levels in patients, showing mortality rates of 0.8% for low risk to 26.7% for high risk. It outperforms other existing models, underscoring its […]

A systematic review evaluated enhanced recovery after surgery (ERAS) protocols specifically for cirrhotic patients undergoing hepatectomy. From 3,123 screened articles, 81 were analyzed, revealing five perioperative items with moderate or high evidence levels. Key recommendations include preoperative ascites control, postoperative venous thromboembolism prophylaxis if coagulation tests are normal, avoidance of systematic drainage, preference for acetate-buffered […]